Citations

Showing 10 of 108104 citations.

Amyloid- and tau-PET imaging in a familial prion kindred
Townley, Ryan , Graff‐Radford, Jonathan , Botha, Hugo , Petersen, Ronald C. , Jack, Clifford R. , Lowe, Val J. , Townley, Ryan A, Jack, Clifford R , Botha, Hugo , Jones, David T. , Knopman, David S. , Boeve, Bradley F.

Mayo Clinic

Neurology Genetics | December 4, 2018 | Volume: 4 | Issue: 6 | Pages: No page available

10.1212/nxg.0000000000000290 | PMID 30584595 Get It

Comparison of Microbial Growth Between Commercial Formula and Blenderized Food for Tube Feeding
Johnson, Teresa W. , Milton, Debra L. , Johnson, Kelly , Epp, Lisa , Spurlock, Amy , Hurt, Ryan T. , Johnson, Kelly, Carter, Holly, Mundi, Manpreet S.

Mayo Clinic

Nutrition in Clinical Practice | December 4, 2018 | Volume: 34 | Issue: 2 | Pages: 257-263

10.1002/ncp.10226 | PMID 30511371 Get It

AbstractBackgroundMany healthcare facilities and providers prohibit blenderized tube feeding (BTF) for patients who request it due to concerns of high microbial load. The current project compared microbial loads of a standard ready‐to‐feed polymeric commercial formula (CF), a BTF made using baby food (BTF‐BF), and a BTF prepared from blending whole food (BTF‐WF), following food safety standards expected of U.S. hospitals.MethodsThree tube‐feeding formulas (CF, BTF‐BF, BTF‐WF) were prepared in a U.S. hospital and delivered in vitro to an unoccupied patient room. Samples were collected at zero hour, 2 hours, and 4 hours and compared for growth of aerobic microorganisms, Staphylococus aureus, coliforms, and Escherichia coli. The experiment was conducted in triplicate, 1 week apart.ResultsNo S. aureus or coliform/E. coli were detected at any time point following preparation, and total bacterial count was well below acceptable limits. All 3 feeding formulas at zero hour, 2 hours, and 4 hours for each of the 3 sampling dates were acceptable for human consumption.ConclusionJudicious BTF recipe selection and adherence to safe food handling provide a safe feeding substrate equivalent to CF in the hospital setting. Due to increased use and interest in BTF by patients and their caregivers, healthcare facilities may need to reexamine their policies prohibiting BTF use.
Brain vital signs detect concussion-related neurophysiological impairments in ice hockey
Fickling, Shaun D. , Smith, Aynsley M., Pawlowski, Gabriela, Hajra, Sujoy Ghosh , Liu, Careesa C. , Farrell, Kyle , Jorgensen, Janelle, Farrell, Kyle J , Song, Xiaowei , Stuart, Michael J. , D’Arcy, Ryan C.N.

Mayo Clinic

Brain | December 3, 2018 | Volume: 142 | Issue: 2 | Pages: 255-262

10.1093/brain/awy317 | PMID 30649205 Get It

The King-Devick test in mixed martial arts: the immediate consequences of knock-outs, technical knock-outs, and chokes on brain functions
Hubbard, Ryan , Stringer, Gene, Peterson, Ken, Carneiro, Mario Roberto Filho Vaz, Savica, Rodolfo , Finnoff, Jonathan T. , Stringer, Gene C.

Mayo Clinic

Brain Injury | December 3, 2018 | Volume: 33 | Issue: 3 | Pages: 349-354

10.1080/02699052.2018.1553068 | PMID 30507317 Get It

Hyperoxia-Induced Cellular Senescence in Fetal Airway Smooth Muscle Cells
Parikh, Pavan , Britt, Rodney D. , Manlove, L., Wicher, Sarah A. , Roesler, A.M., Ravix, Jovanka, Teske, Jacob J. , Kirkland, James L. , Tschumperlin, Daniel J. , Prakash, Y. S. , LeBrasseur, Nathan, Prakash, Y S , Teske, Jacob J , Thompson, Michael A. , Sieck, Gary C. , LeBrasseur, Nathan K. , Pabelick, Christina M.

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | December 3, 2018 | Volume: 61 | Issue: 1 | Pages: 51-60

10.1165/rcmb.2018-0176oc | PMID 30508396 Get It

Abstract Supplemental O2 (hyperoxia; 30–90% O2) is a necessary intervention for premature infants, but it contributes to development of neonatal and pediatric asthma, necessitating better understanding of contributory mechanisms in hyperoxia-induced changes to airway structure and function. In adults, environmental stressors promote formation of senescent cells that secrete factors (senescence-associated secretory phenotype), which can be inflammatory and have paracrine effects that enhance chronic lung diseases. Hyperoxia-induced changes in airway structure and function are mediated in part by effects on airway smooth muscle (ASM). In the present study, using human fetal ASM cells as a model of prematurity, we ascertained the effects of clinically relevant moderate hyperoxia (40% O2) on cellular senescence. Fetal ASM exposed to 40% O2 for 7 days exhibited elevated concentrations of senescence-associated markers, including β-galactosidase; cell cycle checkpoint proteins p16, p21, and p-p53; and the DNA damage marker p-γH2A.X (phosphorylated γ-histone family member X). The combination of dasatinib and quercetin, compounds known to eliminate senescent cells (senolytics), reduced the number of hyperoxia-exposed β-galactosidase–, p21-, p16-, and p-γH2A.X–positive ASM cells. The senescence-associated secretory phenotype profile of hyperoxia-exposed cells included both profibrotic and proinflammatory mediators. Naive ASM exposed to media from hyperoxia-exposed senescent cells exhibited increased collagen and fibronectin and higher contractility. Our data show that induction of cellular senescence by hyperoxia leads to secretion of inflammatory factors and has a functional effect on naive ASM. Cellular senescence in the airway may thus contribute to pediatric airway disease in the context of sequelae of preterm birth.
Surgical Care for Women with Endometrial Cancer in Florida
DeStephano, Christopher C. , Cochuyt, Jordan J., Robertson, Matthew A. , Spaulding, Aaron , Colibaseanu, Dorin T, Spaulding, Aaron C. , Spaulding, Aaron , Osagiede, Osayande , Colibaseanu, Dorin , Robertson, Matthew A.

Mayo Clinic

Journal of Gynecologic Surgery | December 3, 2018 | Volume: 35 | Issue: 3 | Pages: 163-171

10.1089/gyn.2018.0086 | PMID 31289427 Get It

Office-Based Mesenchymal Stem Cell Therapy for the Treatment of Musculoskeletal Disease: A Systematic Review of Recent Human Studies
Law, Luke, Wijnen, André J. van , Eldrige, Jason S. , Mauck, William D. , Pingree, Mathew J., Yang, Juan , Muir, Casey W, Erwin, Patricia J., Bydon, Mohamad , Qu, Wenchun , van Wijnen, Andre J , Hunt, Christine , Nassr, Ahmad , Larson, A. Noelle , Muir, Casey

Mayo Clinic

Pain Medicine | December 3, 2018 | Volume: 20 | Issue: 8 | Pages: 1570-1583

10.1093/pm/pny256 | PMID 30597057 Get It

Abstract Background The use of mesenchymal stem cells (MSCs) in clinical applications for the treatment of musculoskeletal disease is steadily increasing in office-based practice. The so-called “first generation” of MSCs is defined as autologous stem cells that have undergone minimal manipulation and are used for a homologous purpose. Systematic reviews of the clinical trials completed to date of such MSCs enable practitioners to better understand what is currently known about the outcomes and side effects of such treatments. Study Design A systematic review of human clinical studies of office-based MSC therapy for the treatment of painful degenerative musculoskeletal conditions. Methods A search of the Ovid MEDLINE, EMBASE, and Scopus databases was conducted from 2006 through September 2016. Seven hundred sixty-one records were identified from database searching, and two records from reference review of included papers. Studies with human subjects that evaluated treatment of musculoskeletal disease with minimally manipulated MSCs were included. Results Eight studies were included in this review based on selection criteria. A total of 941 patients were included, 841 of whom received cellular products, and no significant adverse events were reported. Symptomatology generally improved, though no differences were seen over controls where present. Conclusion Support in the literature is strongest for the use of bone marrow aspirate concentrate (BMAC) injections for the treatment of knee pain, but applications of the use of BMAC and peripheral blood–derived MSCs for the treatment of hip pain, tendon pain, and disc pain have all been reported. Further research is required, with large randomized controlled trials.
The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy
Laack, Nadia N., Pugh, Stephanie L. , Brown, Paul D. , Fox, Sherry, Choucair, Ali, Khuntia, Deepak , Wendland, Merideth M, Meyers, Christina, Fox, Sherry, Wefel, Jeffrey S. , Meyers, Christina , Suh, John H. , Roberge, David , Bruner, Deborah Watkins

Mayo Clinic

Neuro-Oncology Practice | December 3, 2018 | Volume: 6 | Issue: 4 | Pages: 274-282

10.1093/nop/npy038 | PMID 31386073 Get It

Abstract Background This study evaluated the association between health-related quality of life (HRQOL) and cognition in patients receiving memantine for prevention of cognitive dysfunction during whole-brain radiotherapy (WBRT). Methods Adult patients with brain metastases received WBRT and were randomized to receive placebo or memantine, 20 mg per day, within 3 days of initiating radiotherapy, for 24 weeks. The Functional Assessment of Cancer Therapy-Brain module (FACT-Br) and Medical Outcomes Scale-Cognitive Functioning Scale (MOS-C) were completed in coordination with serial standardized tests of cognitive function. Results Of the 508 eligible patients, 442 (87%) consented to participate in the HRQOL portion and contributed to baseline analyses. Evaluable patients at 24 weeks (n = 246) included surviving patients completing FACT-Br, MOS-C, and objective cognitive assessments (n = 146, 59%) and patients alive at time of missed assessment (n = 100, 41%). Baseline cognitive function correlated significantly with FACT-Br and MOS-C self-reports. All domains of objective cognitive function showed declines over time. Neither FACT-Br nor MOS-C differed between the treatment arms. Emotional and functional well-being subscales of the FACT improved over time while the remainder of the FACT-Br domains remained stable. MOS-C scores declined over time. Conclusion Baseline cognitive function correlated significantly with FACT-Br and MOS-C scores. No by-arm differences in HRQOL were observed despite differences in objective cognitive function. Patient attrition and poor testing compliance remain significant problems in studies of cognitive function of brain metastases patients and further effort is needed to improve compliance with testing and sensitivity of patient-reported measures.
Home Health Care Availability and Discharge Delays in Children With Medical Complexity
Maynard, Roy, Cady, Rhonda , Jacob, Abraham, Ouellette, Yves , Podgorski, Heather, Schiltz, Brenda , Schwantes, Scott, Wheeler, William , Christensen, Eric , Jacob, Abraham

Mayo Clinic

Pediatrics | December 3, 2018 | Volume: 143 | Issue: 1 | Pages: No page available

10.1542/peds.2018-1951 | PMID 30509929 Get It

BACKGROUND: An increasing proportion of pediatric hospital days are attributed to technology-dependent children. The impact that a pediatric home care nursing (HCN) shortage has on increasing length of hospital stay and readmissions in this population is not well documented. METHODS: We conducted a 12-month multisite prospective study of children with medical complexity discharging with home health. We studied the following 2 cohorts: new patients discharging for the first time to home nursing and existing patients discharging from the hospital to previously established home nursing. A modified delay tool was used to categorize causes, delayed discharge (DD) days, and unplanned 90-day readmissions. RESULTS: DD occurred in 68.5% of 54 new patients and 9.2% of 131 existing patients. Lack of HCN was the most frequent cause of DD, increasing costs and directly accounting for an average length of stay increase of 53.9 days (range: 4–204) and 35.7 days (3–63) for new and existing patients, respectively. Of 1582 DDs, 1454 (91.9%) were directly attributed to lack of HCN availability. DD was associated with younger age and tracheostomy. Unplanned 90-day readmissions were due to medical setbacks (96.7% of cases) and occurred in 53.7% and 45.0% of new and existing patients, respectively. CONCLUSIONS: DD and related costs are primarily associated with shortage of HCN and predominantly affect patients new to HCN. Medical setbacks are the most common causes of unplanned 90-day readmissions. Increasing the availability of home care nurses or postacute care facilities could reduce costly hospital length of stay.
The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases
Neavin, Drew , Liu, Duan , Ray, Balmiki, Weinshilboum, Richard M. , Neavin, Drew R , Weinshilboum, Richard M. , Liu, Duan

Mayo Clinic

International Journal of Molecular Sciences | December 3, 2018 | Volume: 19 | Issue: 12 | Pages: 3851

10.3390/ijms19123851 | PMID 30513921 Get It

The aryl hydrocarbon receptor (AHR) is a nuclear receptor that modulates the response to environmental stimuli. It was recognized historically for its role in toxicology but, in recent decades, it has been increasingly recognized as an important modulator of disease—especially for its role in modulating immune and inflammatory responses. AHR has been implicated in many diseases that are driven by immune/inflammatory processes, including major depressive disorder, multiple sclerosis, rheumatoid arthritis, asthma, and allergic responses, among others. The mechanisms by which AHR has been suggested to impact immune/inflammatory diseases include targeted gene expression and altered immune differentiation. It has been suggested that single nucleotide polymorphisms (SNPs) that are near AHR-regulated genes may contribute to AHR-dependent disease mechanisms/pathways. Further, we have found that SNPs that are outside of nuclear receptor binding sites (i.e., outside of AHR response elements (AHREs)) may contribute to AHR-dependent gene regulation in a SNP- and ligand-dependent manner. This review will discuss the evidence and mechanisms of AHR contributions to immune/inflammatory diseases and will consider the possibility that SNPs that are outside of AHR binding sites might contribute to AHR ligand-dependent inter-individual variation in disease pathophysiology and response to pharmacotherapeutics.